# Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

> **NCT01295593** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 33 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** valproic acid and 2-chlorodeoxyadenosine

## Key facts

- **NCT ID:** NCT01295593
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01295593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01295593, "Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01295593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*